The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index; 97 of the 167 sources its claims cite were checked for support.
Can epigenetics shine a light on the biological pathways underlying major mental disorders?
Open accessAbstract
A significant proportion of the global burden of disease can be attributed to mental illness. Despite important advances in identifying risk factors for mental health conditions, the biological processing underlying causal pathways to disease onset remain poorly understood. This represents a limitation to implement effective prevention and the development of novel pharmacological treatments. Epigenetic mechanisms have emerged as mediators of environmental and genetic risk factors which might play a role in disease onset, including childhood adversity (CA) and cannabis use (CU). Particularly, human research exploring DNA methylation has provided new and promising insights into the role of biological pathways implicated in the aetio-pathogenesis of psychiatric conditions, including: monoaminergic (Serotonin and Dopamine), GABAergic, glutamatergic, neurogenesis, inflammatory and immune response and oxidative stress. While these epigenetic changes have been often studied as disease-specific, similarly to the investigation of environmental risk factors, they are often transdiagnostic. Therefore, we aim to review the existing literature on DNA methylation from human studies of psychiatric diseases (i) to identify epigenetic modifications mapping onto biological pathways either transdiagnostically or specifically related to psychiatric diseases such as Eating Disorders, Post-traumatic Stress Disorder, Bipolar and Psychotic Disorder, Depression, Autism Spectrum Disorder and Anxiety Disorder, and (ii) to investigate a convergence between some of these epigenetic modifications and the exposure to known risk factors for psychiatric disorders such as CA and CU, as well as to other epigenetic confounders in psychiatry research.
Overview
CoChat Summary
TL;DR
This narrative review synthesizes human DNA methylation evidence across major psychiatric disorders and argues that several epigenetic signatures map onto transdiagnostic biological pathways, while others are more disorder-specific. It further proposes that childhood adversity and cannabis use may converge on some of these pathways, but causal mediation remains largely untested.
Key findings
- DNA methylation changes in serotoninergic, inflammatory/immune, and neurogenesis/synaptic plasticity pathways appear transdiagnostic; dopaminergic changes are linked mainly to schizophrenia/psychosis, and glutamatergic/GABAergic changes are shared between schizophrenia and autism spectrum disorder. The review notes twin concordance estimates of 41–65% for schizophrenia, ~60% for bipolar disorder, and ~40% for major depression, and that EWAS platforms have moved from ~12,000 CpG sites to >850,000 sites.
- Childhood adversity is associated with DNA methylation changes in HPA-axis genes: NR3C1 methylation is positively correlated with childhood adversity in borderline personality disorder and major depression but negatively correlated with anxiety and PTSD; lower FKBP5 methylation is associated with childhood adversity in psychosis and PTSD; SKA2 interacts with adversity scores in predicting lifetime suicide attempt and mediates associations with reduced cortical thickness and PTSD.
- Cannabis use shows preliminary DNA methylation associations: the largest case–control study reported an epigenome-wide significant differentially methylated CpG in CEMIP; other studies report MARC2, CUX1, CLMN, and SENP7, with cannabis-plus-tobacco analyses identifying AHRR and F2RL3.
- Tobacco, alcohol, and psychiatric medication are important confounders: smoking-associated genes include AHRR, F2RL3, GFI1, and MYO1G; lithium, carbamazepine, and quetiapine are associated with decreased SLC6A4 methylation, contrasting with SLC6A4 hypermethylation reported in bipolar disorder. The review also cites 115 differentially methylated regions in a depression EWAS and 39 DMRs in a monozygotic discordant twin study of major depression.
Methods
- Design: narrative review of existing human DNA methylation studies in psychiatry, covering candidate-gene and epigenome-wide association studies (EWAS), with a focus on transdiagnostic and disorder-specific biological pathways.
- Data: studies of eating disorders, PTSD, bipolar disorder, psychotic disorder, depression, autism spectrum disorder, and anxiety disorders, using tissues including blood, saliva, and post-mortem brain; childhood adversity and cannabis use are reviewed as environmental exposures, with supplementary tables summarizing study characteristics.
- Analysis: narrative synthesis with tables and figures summarizing direction of associations and mediation analyses; no new primary data or formal meta-analysis are reported.
Limitations
- The paper states technical limitations including blood–brain inconsistencies, tissue-type specificity, and the candidate-gene versus EWAS issue; it also notes that most included studies are small and underpowered, except some exceptions such as Hannon et al. (2021).
- The paper states that EWAS-level evidence formally testing mediating pathways between childhood adversity and main clinical conditions is non-existent in humans, and that studies often use broad composite adversity measures, heterogeneous diagnostic categories, and lack information on timing of trauma or cannabis initiation.
- The paper states that genotype, gene expression, and environmental confounders such as tobacco, alcohol, and psychiatric medication are often unaccounted for; evident from the text, as a narrative review it does not describe a systematic search strategy or formal quality appraisal.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
62 Valid · 7 Not valid · 25 Not checked · 31 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Further, EWAS studies have identified differential DNAm in HTR2A (Numata, Ye, Herman, & Lipska, 2014), HTR5A and HTR1E (Nishioka et al., 2013; Pidsley et al., 2014) genes in those with psychosis.”
§ Can epigenetics shine a light on the biological pathways underlying major mental disorders? > Evidence of epigenetic processes in major transdiagnostic pathways > The serotoninergic pathway
What the sources say
- Disputedcites Numata, Ye, Herman, & Lipska, 2014 sourceExperimental — accuracy not yet measured
The Numata et al. citation is attached to HTR2A, not HTR5A or HTR1E. The Discussion (page unavailable) explicitly says the authors did not find methylation changes in HTR2A in their schizophrenia samples. The Results report an association between an HTR2A risk allele and methylation, but not differential HTR2A methylation between patients and controls. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites Nishioka et al., 2013 source
- Partly supportedcites Pidsley et al., 2014 sourceExperimental — accuracy not yet measured
In Results and discussion, under identification of differentially methylated positions in the prefrontal cortex (page unavailable), the paper reports significantly different DNA methylation at HTR5A in schizophrenia patients versus controls. The cited Pidsley paper does not report an HTR1E finding in the passages retrieved for that gene. HTR2A is separately attributed to Numata et al. in the citing sentence, so it is not assessed against Pidsley. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Abundant evidence supports the role of neuroinflammation and altered immune processes in the aetiopathogeneses of various mental conditions (Mazza, Lucchi, Rossetti, & Clerici, 2020; Pariante, 2017).”
§ Can epigenetics shine a light on the biological pathways underlying major mental disorders? > Evidence of epigenetic processes in major transdiagnostic pathways > Immune system and inflammation
What the sources say
- Not checked — no full text of the sourcecites Mazza, Lucchi, Rossetti, & Clerici, 2020 source
- Partly supportedcites Pariante, 2017 sourceExperimental — accuracy not yet measured
Section 5 links inflammation and altered immune responses to risk of depression, particularly in a subgroup of patients. Section 6 says an activated inflammatory system is relevant to psychotic disorders such as schizophrenia, but discusses effects on health, brain structure and outcomes rather than establishing a role in their aetiopathogenesis. The paper therefore supports the claim for depression, but not its broader implication about the origins of various mental conditions or neuroinflammation specifically. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Moreover, MAOA DNAm was negatively correlated to life events in a sample of Panic Disorder (Domschke et al., 2012).”
§ Can epigenetics shine a light on the biological pathways underlying major mental disorders? > The epigenetic signature of childhood adversity and cannabis use > Serotoninergic, dopaminergic and glutamatergic/GABAergic pathways
What the sources say
- Partly supportedcites Domschke et al., 2012 sourceExperimental — accuracy not yet measured
The “Mediating effect of life events on MAOA methylation” section reports that, among female patients with panic disorder, a higher percentage of negative life events was associated with lower methylation at one CpG site. The claim omits those qualifications: the paper does not report a negative correlation for life events generally or for average MAOA methylation across all sites. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Moreover, hypermethylation in the 5-HT3A-R gene appeared to mediate the link between exposure to adversity and higher severity of disease parameters in a mixed sample of BD and Borderline PD (Perroud et al., 2016).”
§ Can epigenetics shine a light on the biological pathways underlying major mental disorders? > The epigenetic signature of childhood adversity and cannabis use > Serotoninergic, dopaminergic and glutamatergic/GABAergic pathways
What the sources say
- Partly supportedcites Perroud et al., 2016 sourceExperimental — accuracy not yet measured
The Mediation Analysis reports that methylation at two 5-HT3A-R CpG sites mediated associations between childhood physical abuse and selected severity outcomes. But the sample included ADHD as well as bipolar disorder and borderline personality disorder, and the methylation–severity associations were not uniformly in the direction of hypermethylation (5HT3A-R Methylation Status According to Severity of Disorder). Page numbers are unavailable in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Furthermore, an EWAS study from patients suffering from Panic Disorder found enrichment in genes involved in the regulation of lymphocytes (Shimada-Sugimoto et al., 2017).”
§ Can epigenetics shine a light on the biological pathways underlying major mental disorders? > Evidence of epigenetic processes in major transdiagnostic pathways > Immune system and inflammation
What the sources say
- Supportedcites Shimada-Sugimoto et al., 2017 source
The Results (Pathway analysis; page unavailable) report that genes annotated to CpG sites associated with panic disorder were analyzed for pathway enrichment. The significantly associated gene sets included “positive regulation of lymphocyte activation,” matching the citing sentence. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
67 more claims · 30 with their cited sources checked
Create a free account to see all 125 claims and to verify the 13 references still open.
- It may state two separate claims as one. 50
- The quote only partly states this claim. 1
- Probably not a substantial claim. 4
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Can epigenetics shine a light on the biological pathways underlying major mental disorders? > Evidence of epigenetic processes in major transdiagnostic pathways > The dopaminergic pathway
“with decreased DNAm in DRD3 (Dai et al., 2014) and DRD4 (Cheng et al., 2014)”
§ Can epigenetics shine a light on the biological pathways underlying major mental disorders? > Evidence of epigenetic processes in major transdiagnostic pathways
“| ↑Cheng et al. (2014) | Candidate gene | Blood | SCZ | |”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Can epigenetics shine a light on the biological pathways underlying major mental disorders? > Evidence of epigenetic processes in major transdiagnostic pathways > The dopaminergic pathway
“with decreased DNAm in DRD3 (Dai et al., 2014) and DRD4 (Cheng et al., 2014)”
§ Can epigenetics shine a light on the biological pathways underlying major mental disorders? > Evidence of epigenetic processes in major transdiagnostic pathways
“| ↑Dai et al. (2014) | Candidate gene | Blood | SCZ | |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Can epigenetics shine a light on the biological pathways underlying major mental disorders? > The epigenetic signature of childhood adversity and cannabis use > Inflammation, oxidative stress, synaptic plasticity and neurogenesis
“Candidate genes studies have linked CA with DNAm changes in BDNF (Moser et al., 2015; Thaler et al., 2014; Weder et al., 2014)”
§ Can epigenetics shine a light on the biological pathways underlying major mental disorders? > Evidence of epigenetic processes in major transdiagnostic pathways
“| Moser et al. (2015) | EWAS | Saliva | PTSD | CA → ↑BDNF meth / ↑BDNF meth-> maternal anxiety |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Can epigenetics shine a light on the biological pathways underlying major mental disorders? > Evidence of epigenetic processes in major transdiagnostic pathways > The serotoninergic pathway
“and obsessive compulsive disorder (OCD) (Domschke et al., 2012).”
§ Can epigenetics shine a light on the biological pathways underlying major mental disorders? > Evidence of epigenetic processes in major transdiagnostic pathways
“| ↓Domschke et al. (2012) | Candidate gene | Blood | Panic disorder | CA → ↓A (MAOA) |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Can epigenetics shine a light on the biological pathways underlying major mental disorders? > Evidence of epigenetic processes in major transdiagnostic pathways > Oxidative stress
“an EWAS study in Borderline PD found differences in methylation in GCT6, which is important in glutathione metabolism (Arranz et al., 2021).”
§ Can epigenetics shine a light on the biological pathways underlying major mental disorders? > Evidence of epigenetic processes in major transdiagnostic pathways
“| GGT6 | GGT6 | GGT6 | GGT6 | GGT6 | | Arranz et al. (2021) | EWAS | Blood | Borderline PD | |”
2 more findings
Create a free account to see every finding of this check.
Citations
Cites
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325 · cited 1×
“Epigenetic modifications refer to functional changes in DNA structural packaging or associated proteins without structural alteration of the DNA sequence itself (Jaenisch & Bird, 2003).”
BackgroundAssociations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Varese, F., Smeets, F., Drukker, M., Lieverse, R., Lataster, T., Viechtbauer, W., Read, J., van Os, J., & Bentall, R. P. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs050 · Cited by 2,436 · cited 2×
“Thirdly, we will explore if the existing findings from studies on DNAm changes associated with CA and CU, two of the environmental exposures most consistently associated with psychiatric disorders (Lindert et al., 2014; Mandelli, Petrelli, & Serretti, 2015; Marconi, Di Forti, Lewis, Murray, & Vassos, 2016; Sideli, Qui…”
BackgroundThe environment and schizophrenia
van Os, J., Kenis, G., & Rutten, B. P. F. (2010) · Nature · doi:10.1038/nature09563 · Cited by 1,572
Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions
Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J. C., Pariante, C. M., Pace, T. W. W., Mercer, K. B., Mayberg, H. S., Bradley, B., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3275 · Cited by 1,447
A mega-analysis of genome-wide association studies for major depressive disorder
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke, S., Wray, N. R., Lewis, C. M., Hamilton, S. P., Weissman, M. M., Breen, G., Byrne, E. M., Blackwood, D. H. R., Boomsma, D. I., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.21 · Cited by 1,120
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw003 · Cited by 899 · cited 2×
“Cannabis use CU and in particular heavy use (Marconi et al., 2016) has been consistently associated with increased risk for PD, but to a lesser degree for other psychiatric conditions (Sideli, Trotta, Spinazzola, La Cascia, & Di Forti, 2020b).”
BackgroundSelf-citationNew insights into symptoms and neurocircuit function of anorexia nervosa
Kaye, W. H., Fudge, J. L., & Paulus, M. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2682 · Cited by 843
Tobacco smoking leads to extensive genome-wide changes in DNA methylation
Zeilinger, S., Kühnel, B., Klopp, N., Baurecht, H., Kleinschmidt, A., Gieger, C., Weidinger, S., Lattka, E., Adamski, J., Peters, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063812 · Cited by 824 · cited 2×
“A number of publications have identified robust associations between tobacco smoking and DNAm (Elliott et al., 2014; Shenker et al., 2013; Tsaprouni et al., 2014; Zeilinger et al., 2013), with a number of genes (e.”
Background
Research works printed but not linked: 2
- Thaler, 2017, Advances in Experimental Medicine and Biology, 978, 93
- Wong, C. , Smith, R. , Hannon, E. , Ramaswami, G. , Parikshak, N. , Assary, E. , … Sun, W. (2018). Genome-wide DNA methylation profiling identifies convergent molecular signatures associated with idiopathic and syndromic forms of autism in postmortem human brain tissue. 28(13), 394387. · DOI · Paper page
Cited by
Cheng, J., Hu, H., Ju, Y., Liu, J., Wang, M., Liu, B., & Zhang, Y. (2024) · General Psychiatry · doi:10.1136/gpsych-2023-101374 · Cited by 196
Mendelian randomization: causal inference leveraging genetic data
Chen, L. G., Tubbs, J. D., Liu, Z., Thach, T., & Sham, P. C. (2024) · Psychological Medicine · doi:10.1017/s0033291724000321 · Cited by 97
“…being applied to a wide range of multi-omics data, including metabolomics (Liu et al., 2017; Richardson et al., 2022), epigenetic markers (Alameda et al., 2022; Jamieson et al., 2020; Richardson et al., 2019), single-cell transcriptomics (Haglund et al., 2022), and the brain connec-tome…”
BackgroundAdverse effects of early-life stress: focus on the rodent neuroendocrine system
Lee, S. H., & Jung, E. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.377587 · Cited by 52
“These results may be influenced by epigenetic factors because an increasing number of studies have reported that ELS induces the expression of epigenetic-related genes, such as histone deacetylase and histone acetylase (Alameda et al., 2022).”
BackgroundEpigenetic Mechanism of Early Life Stress-Induced Depression: Focus on the Neurotransmitter Systems
Cheng, Z., Su, J., Zhang, K. N., Jiang, H., & Li, B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.929732 · Cited by 45
Dzhambov, A. M., Lercher, P., Vincens, N., Waye, K. P., Klatte, M., Leist, L., Lachmann, T., Schreckenberg, D., Belke, C., Ристовска, Г., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116452 · Cited by 40
Metadata
- Authors
- Alameda, L., Trotta, G., Quigley, H., Rodriguez, V., Gadelrab, R., Dwir, D., Dempster, E., Wong, C. C. Y., & Forti, M. D.
- Affiliations
- King's College London (GB)
- Centre Hospitalier Universitaire Vaudois (CH)
- University of Exeter (GB)
- Corresponding author
- Forti, Marta Di
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2022-02-23
- Volume
- 52
- Issue
- 9
- Pages
- 1645-1665
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- PMC
- PMC9280283
- OpenAlex
- W4213452157
- Semantic Scholar
- 43c7a37cb85db0c395f278c28e0f2c244f9ac5b1
- Cited by
- 60
- References
- 183
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 17 · 2023: 8 · 2022: 7
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Psychological Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- IRIS (submittedVersion, cc-by)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Funders
- swiss national foundation (P2LAP3_171804)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Social Sciences › Psychology › Clinical Psychology › Child Abuse and Trauma
- Keywords
- epigenetics, DNA methylation, mental illness, childhood adversity, cannabis use, monoaminergic systems, GABAergic system, glutamatergic system, neurogenesis, neuroinflammation, oxidative stress, eating disorders, post-traumatic stress disorder, bipolar disorder, psychosis, depression, autism spectrum disorder, anxiety disorders, psychiatric risk factors
- MeSH terms
- Autism Spectrum Disorder, Mental Disorders, Humans, Psychotic Disorders, Stress Disorders, Post-Traumatic, DNA Methylation, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Can epigenetics shine a light on the biological pathways underlying major mental disorders? https://app.cochat.ai/papers/10.1017/s0033291721005559
- The paper
- Alameda, L., Trotta, G., Quigley, H., Rodriguez, V., Gadelrab, R., Dwir, D., Dempster, E., Wong, C. C. Y., & Forti, M. D. (2022). Can epigenetics shine a light on the biological pathways underlying major mental disorders? Psychological Medicine. https://doi.org/10.1017/s0033291721005559
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.